Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.
暂无分享,去创建一个
Shan Tan | Warren D D'Souza | Wei Lu | Hao Zhang | M. Suntharalingam | W. D'Souza | W. Lu | H. Zhang | Wengen Chen | Shan Tan | S. Kligerman | Grace J. Kim | Wengen Chen | Grace Kim | Seth Kligerman | Mohan Suntharalingam
[1] R. Munden,et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. , 2004, The Annals of thoracic surgery.
[2] R. Wahl,et al. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.
[3] B. Krause,et al. 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer , 2009, Journal of Nuclear Medicine.
[4] Otto S Hoekstra,et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review. , 2005, Radiology.
[5] K. Polyak,et al. Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.
[6] M. Suntharalingam,et al. Outcomes After Trimodality Therapy for Esophageal Cancer: The Impact of Histology on Failure Patterns , 2011, American journal of clinical oncology.
[7] K. Geisinger,et al. Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal Cancer , 2006, Annals of surgery.
[8] K Kubota,et al. From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology , 2001, Annals of nuclear medicine.
[9] A. Ruol,et al. Interval Between Neoadjuvant Chemoradiotherapy and Surgery for Squamous Cell Carcinoma of the Thoracic Esophagus: Does Delayed Surgery Have an Impact on Outcome? , 2010, Annals of surgery.
[10] John L. Humm,et al. Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[11] Shan Tan,et al. Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy. , 2013, International journal of radiation oncology, biology, physics.
[12] M. Hatt,et al. Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer , 2011, The Journal of Nuclear Medicine.
[13] J. Bradley,et al. Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] E. Halpern,et al. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. , 2002, Radiology.
[15] Nils Lehmann,et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Jason Weston,et al. Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.
[17] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[18] Nagara Tamaki,et al. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] K. Geisinger,et al. Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] J. Ajani,et al. Does the timing of esophagectomy after chemoradiation affect outcome? , 2012, The Annals of thoracic surgery.
[21] R. M. Kwee. Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review. , 2010, Radiology.
[22] C. Tseng,et al. Interval Between Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma: Does Delayed Surgery Impact Outcome? , 2013, Annals of Surgical Oncology.
[23] Zixiang Xiong,et al. Optimal number of features as a function of sample size for various classification rules , 2005, Bioinform..
[24] J. Petiot,et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations , 1994, Cancer.
[25] B. Loo,et al. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer. , 2012, International journal of radiation oncology, biology, physics.
[26] T. Conroy,et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] D. Sugarbaker,et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] F O'Sullivan,et al. Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET. , 2005, Biostatistics.